Correlation Between Monte Rosa and Merus BV
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Merus BV, you can compare the effects of market volatilities on Monte Rosa and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Merus BV.
Diversification Opportunities for Monte Rosa and Merus BV
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Monte and Merus is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Monte Rosa i.e., Monte Rosa and Merus BV go up and down completely randomly.
Pair Corralation between Monte Rosa and Merus BV
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to under-perform the Merus BV. In addition to that, Monte Rosa is 1.88 times more volatile than Merus BV. It trades about -0.13 of its total potential returns per unit of risk. Merus BV is currently generating about -0.12 per unit of volatility. If you would invest 4,209 in Merus BV on October 20, 2024 and sell it today you would lose (264.00) from holding Merus BV or give up 6.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monte Rosa Therapeutics vs. Merus BV
Performance |
| Timeline |
| Monte Rosa Therapeutics |
| Merus BV |
Monte Rosa and Merus BV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monte Rosa and Merus BV
The main advantage of trading using opposite Monte Rosa and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.| Monte Rosa vs. Agilent Technologies | Monte Rosa vs. Equillium | Monte Rosa vs. 23Andme Holding Co | Monte Rosa vs. DiaMedica Therapeutics |
| Merus BV vs. Anebulo Pharmaceuticals | Merus BV vs. Adagene | Merus BV vs. Acrivon Therapeutics, Common | Merus BV vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| CEOs Directory Screen CEOs from public companies around the world |